Advertisement

Internal and Emergency Medicine

, Volume 12, Issue 5, pp 573–576 | Cite as

Claims-based or clinical models for predicting 90-day post-pulmonary embolism outcomes

  • Cecilia BecattiniEmail author
  • Giancarlo Agnelli
IM - COMMENTARY

The clinical presentation of pulmonary embolism is remarkably variable. The features of clinical presentation may be used to predict the short-term clinical outcome of patients with pulmonary embolism [1, 2]. Based on clinical presentation, patients’ features and presence/absence of right ventricle overload, at least three risk categories of patients with acute pulmonary embolism at expected low, intermediate or high risk for short-term death can be identified [3]. The final aim of risk stratification is to tailor treatment and patients’ management according to the expected risk for death [4].

The paper by Christine Cohn et al. published in this issue of the Journal addresses the issue of risk stratification in patients with acute pulmonary embolism [5]. The authors report on an analysis of the Veteran Health Administration database on the accuracy of IMPACT and simplified PESI models for risk stratification of pulmonary embolism. The risk for death at 90 days, readmission for...

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

Statement of human and animal rights

This article does not contain any studies with animals. All procedures performed in studies involving human participants were in accordance with the 1984 Helsinki Declaration.

Informed consent

The study is a retrospective one, thus informed consent is not applicable.

References

  1. 1.
    Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353:1386–1389CrossRefPubMedGoogle Scholar
  2. 2.
    Casazza F, Becattini C, Bongarzoni A, Cuccia C, Roncon L, Favretto G, Zonzin P, Pignataro L, Agnelli G (2012) Clinical features and short term outcomes of patients with acute pulmonary embolism. The Italian Pulmonary Embolism Registry (IPER). Thromb Res 130:847–852CrossRefPubMedGoogle Scholar
  3. 3.
    Becattini C, Agnelli G, Lankeit M, Masotti L, Pruszczyk P, Casazza F, Vanni S, Nitti C, Kamphuisen P, Vedovati MC, De Natale MG, Konstantinides S (2016) Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. Eur Respir J 48:780–786CrossRefPubMedGoogle Scholar
  4. 4.
    Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M, Authors/Task Force Members (2014) ESC guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS). Eur Heart J 2014(35):3033–3069Google Scholar
  5. 5.
    Kohn CG, Weeda ER, Kumar N, Wells PS, Peacock WF, Fermann GJ, Wang L, Baser O, Schein JR, Crivera C, Coleman CI (2017) External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans. Intern Emerg Med. doi: 10.1007/s11739-017-1625-9 PubMedGoogle Scholar
  6. 6.
    Guercini F, Mommi V, Camporese G, Tonello C, Imberti D, Benedetti R, De Bartolomeo G, Di Lecce L, Romeo F, Agnelli G (2016) The management of patients with venous thromboembolism in Italy: insights from the PREFER in VTE registry. Intern Emerg Med 11:1095–1102CrossRefPubMedGoogle Scholar
  7. 7.
    Elias A, Mallett S, Daoud-Elias M, Poggi JN, Clarke M (2016) Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis. BMJ Open 6:e010324CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, Roy PM, Fine MJ (2005) Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 172:1041–1046CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Jimenez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, Otero R, Monreal M, Muriel A, Yusen RD (2010) Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 170:1383–1389CrossRefPubMedGoogle Scholar
  10. 10.
    Venetz C, Jiménez D, Mean M, Aujesky D (2011) A comparison of the original and simplified Pulmonary Embolism Severity Index. Thromb Haemost 106:423–428CrossRefPubMedGoogle Scholar
  11. 11.
    Polo Friz H, Molteni M, Del Sorbo D, Pasciuti L, Crippa M, Villa G, Meloni DF, Primitz L, Galli A, Rognoni M, Cavalieri d’Oro L, Arpaia G, Cimminiello C (2015) Mortality at 30 and 90 days in elderly patients with pulmonary embolism: a retrospective cohort study. Intern Emerg Med 10:431–436CrossRefPubMedGoogle Scholar
  12. 12.
    Aujesky D, Roy PM, Verschuren F, Righini M, Osterwalder J, Egloff M, Renaud B, Verhamme P, Stone RA, Legall C, Sanchez O, Pugh NA, N’gako A, Cornuz J, Hugli O, Beer HJ, Perrier A, Fine MJ, Yealy DM (2011) Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 378:41–48CrossRefPubMedGoogle Scholar
  13. 13.
    Maestre A, Trujillo-Santos J, Riera-Mestre A, Jiménez D, Di Micco P, Bascuñana J, Vela JR, Peris L, Malfante PC, Monreal M; RIETE Investigators (2015) Identification of low-risk patients with acute symptomatic pulmonary embolism for outpatient therapy. Ann Am Thorac Soc 12:1122–1129Google Scholar
  14. 14.
    Zondag W, Mos IC, Creemers-Schild D, Hoogerbrugge AD, Dekkers OM, Dolsma J, Eijsvogel M, Faber LM, Hofstee HM, Hovens MM, Jonkers GJ, van Kralingen KW, Kruip MJ, de Vlasveld T, Vreede MJ, Huisman MV, Hestia Study Investigators (2011) Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost 9:1500–1507CrossRefPubMedGoogle Scholar
  15. 15.
    den Exter PL, Zondag W, Klok FA, Brouwer RE, Dolsma J, Eijsvogel M, Faber LM, van Gerwen M, Grootenboers MJ, Heller-Baan R, Hovens MM, Jonkers GJ, van Kralingen KW, Melissant CF, Peltenburg H, Post JP, van de Ree MA, de Vlasveld LT, Vreede MJ, Huisman MV, Vesta Study Investigators (2016) Efficacy and safety of outpatient treatment based on the hestia clinical decision rule with or without N-terminal pro-brain natriuretic peptide testing in patients with acute pulmonary embolism. A randomized clinical trial. Am J Respir Crit Care Med 194:998–1006CrossRefGoogle Scholar
  16. 16.
    Weeda ER, Kohn CG, Fermann GJ, Peacock WF, Tanner C, McGrath D, Crivera C, Schein JR, Coleman CI (2016) External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches. Thromb J 14:7CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Søgaard KK, Schmidt M, Pedersen L, Horváth-Puhó E, Sørensen HT (2014) 30-year mortality after venous thromboembolism: a population-based cohort study. Circulation 130:829–836CrossRefPubMedGoogle Scholar
  18. 18.
    Park B, Messina L, Dargon P, Huang W, Ciocca R, Anderson FA (2009) Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample. Chest 136:983–990CrossRefPubMedGoogle Scholar
  19. 19.
    Dentali F, Di Minno MN, Gianni M, Ambrosino P, Squizzato A, Ageno W (2015) Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature. Intern Emerg Med 10:507–514CrossRefPubMedGoogle Scholar
  20. 20.
    Becattini C, Agnelli G (2015) Is there still a place for thrombolytic therapy in hemodynamically stable patients with acute pulmonary embolism? No. Intern Emerg Med 10:281–284CrossRefPubMedGoogle Scholar
  21. 21.
    Meyer G, Sanchez O, Planquette B (2015) Is there still a place for thrombolytic therapy in hemodynamically stable patients with acute pulmonary embolism? Yes. Intern Emerg Med 10:277–280CrossRefPubMedGoogle Scholar

Copyright information

© SIMI 2017

Authors and Affiliations

  1. 1.Stroke Unit, Division of Internal and Cardiovascular MedicineUniversity of PerugiaPerugiaItaly

Personalised recommendations